Bausch Health ehemals VALEANT PHARMA Allergan-Übernahme beflügelt (Seite 193)

[marty44]

Antwort auf Beitrag Nr.: 55.842.096 von marty44 am 28.09.17 13:23:50

[marty44]

Antwort auf Beitrag Nr.: 55.787.253 von marty44 am 20.09.17 18:03:43

[marty44]

Solta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing

https://ih.advfn.com/p.php?pid=nmona&article=75790636

LAVAL, Quebec, Oct. 4, 2017 /CNW/ -- Solta Medical, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant"), announced today that its Thermage FLX™ System received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to non-invasively smooth skin on the face, eyes and body.

Thermage FLX is the newest generation of Thermage® technologies known for non-invasively reducing the appearance of fine lines and wrinkles. The system uses patented radiofrequency technology to create a uniform heating effect in the deep collagen-rich layers of the skin. This gentle heating tightens existing collagen and stimulates the production of new collagen, all with little-to-no downtime for the patient. The Thermage FLX features a new optimized energy delivery algorithm, known as AccuREP™ technology, which automatically measures and precisely tunes the amount of energy delivered to the patient and treatment area. The system also features a new vibrating hand-piece to help enhance patient comfort, and a new, larger treatment tip that reduces treatment time by 25 percent.

"As the demand for skin tightening procedures continues to rise, we have continued to evolve and enhance our Thermage technology to meet the needs of skincare physicians and their patients who are looking for ways to achieve smoother skin with natural looking results," said Joseph C. Papa, chairman and CEO, Valeant. "With the approval of the Thermage FLX through our Solta business, a pioneer and leader in the aesthetic industry, treatments are now faster and more patient-friendly."

The non-invasive treatment of addressing the look and feel of aging skin using radiofrequency energy was first introduced by Thermage more than 15 years ago. Since that time, the technology has continued to evolve, and to date, two million Thermage treatments for women and men of all ethnicities have been performed.

"Being among the first adopters of the technology, I have confidently used the system for over a decade, as it is the center-piece of a successful skin tightening program," said Michael S. Kaminer, M.D., founding partner of SkinCare Physicians. "The Thermage system, backed by more than 50 clinical studies, is the gold standard in our practice and our most popular skin smoothing treatment. I'm excited to see what the new Thermage FLX system has to offer as each subsequent version has proven to exceed my expectations."

The new Thermage FLX system is expected to be commercially available before the end of 2017.

[marty44]

iNova Multiples Are Unimpressive - Uncertainty Persists For Valeant

https://seekingalpha.com/article/4111443-inova-multiples-uni…

[marty44]

Antwort auf Beitrag Nr.: 55.872.487 von marty44 am 03.10.17 18:13:58

Valeant Pharmaceuticals Intl Inc’s (VRX) Bausch + Lomb Launches Biotrue ONEday in Europe

https://www.smarteranalyst.com/2017/10/03/valeant-vrx-bausch…

[marty44]

Valeant: Still Deep in Junk Territory

http://www.barrons.com/articles/valeant-still-deep-in-junk-t…

[marty44]

https://www.reuters.com/article/us-redhill-boweldrug/redhill…

...
Other drugs to treat IBS-D in both men and women include Valeant Pharmaceuticals International Inc’s Xifaxan and Allergan Plc’s Viberzi.
...

[marty44]

Valeant's B+L launches new Biotrue ONEday contact lens in Europe

https://seekingalpha.com/news/3298960-valeants-b-l-launches-…

[marty44]

Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Set for Near-100% Return

https://investorplace.com/2017/10/valeant-pharmaceuticals-in…

[ODI01]

http://www.prnewswire.com/news-releases/valeant-will-release…